John Paul SanGiovanni

Dr. John Paul SanGiovanni

Center for the Study of Nutrient-Responsive Systems, University of Arizona Department of Nutritional Sciences and University of Arizona BIO5 Institute; Rockville, MD and Tucson AZ

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2005 in Science
Verified
Journal Article
Closed access
PDF file
RKRobert J. Klein
Robert J. Klein
CZCaroline Zeiss
Caroline Zeiss
ECEmily Y. Chew
Emily Y. Chew
JTJen-Yue Tsai
Jen-Yue Tsai
RSRichard S. Sackler
Richard S. Sackler
JHJosephine Hoh
Josephine Hoh
Age-related macular degeneration (AMD) is a major cause of blindness in the elderly. We report a genome-wide screen of 96 cases and 50 controls for polymorphisms associated with AMD. Among 116,204 single-nucleotide polymorphisms genotyped, an intronic and common variant in the complement factor H gene ( CFH ) is strongly associated with AMD (nominal P value <10 -7 ). In individuals homozygous for the risk allele, the likelihood of AMD is increased by a factor of 7.4 (95% confidence interval 2.9 to 19). Resequencing revealed a polymorphism in linkage disequilibrium with the risk allele representing a tyrosine-histidine change at amino acid 402. This polymorphism is in a region of CFH that binds heparin and C-reactive protein. The CFH gene is located on chromosome 1 in a region repeatedly linked to AMD in family-based studies.

1 January 2005 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
JSJohn Paul SanGiovanni
John Paul SanGiovanni
ECEmily Y. Chew
Emily Y. Chew

24 June 2007 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KCKip M Connor
Kip M Connor
JSJohn Paul SanGiovanni
John Paul SanGiovanni
CLChatarina Lofqvist
Chatarina Lofqvist
CAChristopher M Aderman
Christopher M Aderman
JCJing Chen
Jing Chen
LSLois Smith
Lois Smith

1 June 2000 in Pediatrics
Verified
Journal Article
Closed access
PDF file
JSJohn Paul SanGiovanni
John Paul SanGiovanni
SPSocorro Parra-Cabrera
Socorro Parra-Cabrera
GCGraham A Colditz
Graham A Colditz
CBCatherine S. Berkey
Catherine S. Berkey
JDJohanna Dwyer
Johanna Dwyer
Objective.: To derive combined estimates of visual resolution acuity differences between healthy preterm infants consuming different compositions and ratios of essential fatty acids (EFAs) and docosahexaenoic acid (DHA), an omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA). Data Sources.: Electronic biomedical reference database (Medline and Health Star from 1965 to July 1999) searches with index terms omega-3, n-3, infant, vision, acuity, and human. Current review article, monograph, and book chapter bibliography/reference section hand searches. Study Selection.: A total of 5 original articles and 4 review chapters were reviewed for details on study design, conduct, and outcome. Four prospective trials of EFA/LCPUFA supplementation were included in these analyses. For behaviorally based outcomes, there were 2 randomized comparisons each at ≤1, 2, 6, 9, and 12 months of corrected age and 4 randomized comparisons at 4 months of corrected age. For electrophysiologically based outcomes (visual-evoked potential), there were 2 randomized comparisons each at ≤1 and ∼4 months of corrected age. Data Extraction.: Dietary composition and EFA/LCPUFA balance, study design, and analytic characteristics (duration of feeding, source of EFAs/LCPUFAs, number of subjects in study population, number of subjects analyzed, and basis for estimating age), and experiment-based characteristics (location, number or sites, design, vision tests employed, testing protocol, and ophthalmic examination) were recorded independently by 2 researchers with a standardized protocol. Data Synthesis.: The relative difference in visual resolution acuity between groups of infants who received a source of dietary EFAs/LCPUFAs and groups who did not was computed and then analyzed with the DerSimonian and Laird random-effects method. Results.: Analysis of the randomized comparisons (DHA-supplemented formula vs DHA-free formula) showed significant differences in visual resolution acuity at 2 and 4 months of age. Combined estimates of behaviorally based visual resolution acuity differences at these ages were .47 ± .14 octaves and .28 ± .08 octaves, respectively. A 1-octave difference is a reduction in the width of the stimulus elements by 50%. Conclusion.: These results support efficacy of n-3 LCPUFA intake in early visual system development, although supplementation safety issues still must be addressed through larger randomized trials. Whether n-3 intake confers lasting advantage in visually based process development across the life-span is still to be determined.

1 December 2009 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
AGAREDS Research Group
AREDS Research Group
JSJohn Paul SanGiovanni
John Paul SanGiovanni
EAElvira Agrón
Elvira Agrón
AMA Dhananjayan Meleth
A Dhananjayan Meleth
GRGeorge F Reed
George F Reed
ECEmily Y Chew
Emily Y Chew
Background:ω−3 (n–3) Long-chain polyunsaturated fatty acids (LCPUFAs) affect processes implicated in vascular and neural retinal pathogenesis and thus

1 March 2000 in Early Human Development
Verified
Journal Article
Closed access
JSJohn Paul SanGiovanni
John Paul SanGiovanni
CBCatherine S Berkey
Catherine S Berkey
JDJohanna Dwyer
Johanna Dwyer
GCGraham A Colditz
Graham A Colditz